Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beta Therapeutics Pty. Ltd.

www.betatherapeutics.com.au

Latest From Beta Therapeutics Pty. Ltd.

Deal Watch: Boehringer, Epizyme Team Up To Develop Epigenetic Cancer Therapies

BI and Epizyme’s collaboration will focus on developing novel cancer drugs targeting helicase and HAT enzyme dysregulation. MorphoSys and I-Mab will partner on developing an IO therapy targeting C5aR.

Deals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Inflammation
  • Metabolic Disorders
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Beta Therapeutics Pty. Ltd.
  • Senior Management
  • Keats Nelms, PhD, CEO
  • Contact Info
  • Beta Therapeutics Pty. Ltd.
    Level 6, 121 Marcus Clarke St.
    Canberra, ACT 2601
    Australia
Advertisement
Advertisement
UsernamePublicRestriction

Register